Price data is not available
Trinity Biotech PLC
TRIBNASDAQ
Trinity Biotech (TRIB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Trinity Biotech (TRIB) last issued guidance on March 10, 2026 for Q4 2025. The company guided revenue in the range of $11.5M - $12.5M for the period.
Compared to prior guidance, Trinity Biotech lowered its revenue forecast from a prior range of $15.5M - $16M.
Trinity Biotech has issued 3 guidance updates between October 3, 2023 and March 10, 2026. During this period, the company raised its outlook 1 time and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-0.31 | $-0.32 | $-0.20 |
| Actual | $-0.23 | $-0.90 | $-0.28 | $-0.32 |
| Surprise | — | -190.3% | +12.5% | -60.0% |
| Revenue | ||||
| Estimate | — | — | $15.0M | $14.5M |
| Actual | $10.8M | $11.1M | $14.3M | $10.8M |
| Surprise | — | — | -4.59% | -25.3% |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | May 6, 2026 | $-0.90 | $-0.31 | -190.3 % |
| Q3 | Dec 23, 2025 | $-0.28 | $-0.32 | 12.5 % |
| Q2 | Dec 23, 2025 | $-0.32 | $-0.20 | -60.0 % |
| Q1 | Jul 1, 2025 | $-0.48 | $-0.15 | -220.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Dec 23, 2025 | $14.31M | $15.00M | -4.59 % |
| Q2 | Dec 23, 2025 | $10.83M | $14.50M | -25.3 % |
| Q1 | Jul 1, 2025 | $7.57M | $14.50M | -47.8 % |
| Q4 | May 15, 2025 | $15.86M | $16.50M | -3.90 % |
